newsfilter
← Latest News
GlobeNewswire·

Context Therapeutics Announces Chief Medical Officer Transition

PHILADELPHIA, May 05, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. ("Context" or "Company") (NASDAQ:CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid